Finance

Lists
Why is 603334 down 2.16%?
Dive Deeper
603334:SHA
Suzhou Fengbei Biotech Stock Co Ltd
CNÂ¥29.48
-2.16%
(-0.65) 1D
Oct 23, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603334...
Open
CNÂ¥29.45
High
CNÂ¥29.87
Low
CNÂ¥27.80
Mkt. cap
4.49B
Avg. vol.
1.81M
Volume
2.81M
Dividend
1.19%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 8, 2026
P/E ratio
16.31
52-wk high
CNÂ¥76.00
52-wk low
CNÂ¥27.80
EPS
CNÂ¥1.81
No. of employees
395
Open
CNÂ¥29.45
High
CNÂ¥29.87
Low
CNÂ¥27.80
Mkt. cap
4.49B
Avg. vol.
1.81M
Volume
2.81M
Dividend
1.19%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 8, 2026
P/E ratio
16.31
52-wk high
CNÂ¥76.00
52-wk low
CNÂ¥27.80
EPS
CNÂ¥1.81
No. of employees
395
News stories
From web sources and news partners
About Suzhou Fengbei Biotech Stock Co Ltd
CEO-
Employees395
FoundedJul 25, 2014
Headquarters-
SectorCommodity chemical
Websitesz-fb.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
773.28M
919.39M
1.11B
1.24B
Cost of goods sold
710.00M
866.02M
1.04B
1.15B
Cost of revenue
710.00M
866.02M
1.04B
1.15B
Research and development expenses
16.68M
17.05M
14.25M
18.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.42M
19.69M
13.50M
16.50M
Operating expense
25.41M
28.96M
17.48M
32.62M
Total operating expenses
735.41M
894.98M
1.06B
1.19B
Operating income
37.86M
24.41M
49.29M
51.23M
Other non operating income
1.17M
-1.77M
-3.63M
2.58M
EBT including unusual items
34.12M
25.80M
45.84M
47.06M
EBT excluding unusual items
35.60M
20.35M
45.86M
47.52M
Income tax expense
1.89M
2.58M
4.93M
6.50M
Effective tax rate
5.52%
9.98%
10.75%
13.82%
Other operating expenses
-6.88M
-6.52M
-8.95M
-14.86M
Net income
32.24M
23.26M
40.88M
40.55M
Net profit margin
4.17%
2.53%
3.69%
3.28%
Earnings per share
-
-
-
-
Interest and investment income
120.75K
673.13K
839.14K
656.82K
Interest expense
-1.46M
-2.86M
-637.21K
-476.87K
Net interest expenses
-1.34M
-2.19M
201.94K
179.96K
Depreciation and amortization charges
-
-
-
-
EBITDA
41.91M
31.41M
56.29M
61.31M
Gain or loss from assets sale
729.00
-32.84K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps